Article Abstract
Letter to the Editor
Sir: Risperidone is an atypical antipsychotic drug distinguished from conventional neuroleptics by its antagonism of serotonin receptors of the 5-HT2A and 5-HT7 subtypes while having a similar affinity for dopamine D2 receptors. The novel pharmacologic profile of risperidone suggests the possibility of other therapeutic applications, particularly in disorders putatively associated with abnormal central serotonergic function. Obsessive-compulsive disorder (OCD) is such a disorder, and recent reports suggest that risperidone may be an effective adjunct to treatment of OCD with selective serotonin reuptake inhibitors (SSRIs).
From the Editors
New Series
The JCP Podcast
Insightful, evidence-based conversations on the latest in psychiatric care — from the editors of JCP.
Download Free PDF
This PDF is free for all visitors!
